About
Oculogica is a neuro-diagnostic company dedicated to improving the assessment of brain injuries, particularly concussions. Founded by neurosurgeon Dr. Uzma Samadani, the company has developed the EyeBOX®, an advanced eye-tracking device that is FDA-cleared and designed to aid clinicians in diagnosing concussions. This innovative device is baseline-free, meaning it does not require prior patient data for comparison, making the diagnosis process quicker and more straightforward. The EyeBOX® provides objective, non-invasive data that enhances clinical assessments and reduces guesswork. It has also received CE Mark certification, allowing Oculogica to expand its reach into European markets. The company focuses on improving patient outcomes in traumatic brain injury and concussion care, serving healthcare professionals, sports teams, and patients. Oculogica operates from its headquarters in Manhattan, New York City, positioning itself strategically within a hub of medical innovation and research.
Technologies
Keywords
Company Information
-
Employees 12
-
Founded 2013
-
Annual Revenue $12100000
-
Total Funding $28379855
Location
33 Irving Place, New York, New York, United States, 10003